Aug. 18 at 12:38 PM
$HAE Haemonetics announces supply agreement with CSL Plasma
In a regulatory filing this morning, the company stated: "On August 14, 2026, Haemonetics Corporation entered into a supply agreement with CSL Plasma Inc. pursuant to which CSL may utilize the Company's NexSys PCS(R) devices with Persona(R) PLUS technology and purchase related disposables in the United States. The supply agreement is non-exclusive and does not contain minimum purchase commitments. Haemonetics anticipates CSL to transition a portion of its U.S. plasma collection centers to the Company's devices and disposables, but the scope and timing of implementation have not yet been determined. Accordingly, the Company is not updating its previously issued fiscal 2027 guidance at this time. The Company expects to provide an update regarding the anticipated impact of the agreement on its fiscal 2027 financial results in connection with its second fiscal quarter earnings call in November 2026."
